Respira has received reports of employment scams that purport to extend job offers or seek financial commitments from job candidates. Unsuspecting job seekers have reported receiving unsolicited contacts by phone, or text from individual(s) claiming to be or represent Respira recruiter(s).? ? Be advised that Respira does not extend unsolicited employment offers. Respira also does not conduct its recruitment process through text messages. Furthermore, Respira does not charge prospective employees with any fees or a security deposit during the recruitment process. If a person claims to provide recruitment services for Respira for a fee to the applicant or offers an unsolicited job offer, please be advised that the person is not affiliated in any way with Respira. If you are interested in an employment opportunity with Respira, please visit our official Jobs page on LinkedIn. Job postings that do not link to this page are not legitimate and might be fraudulent. ? You may report any such behavior via?[email protected]. If you have been defrauded or suspect identity theft as a result of an employment scam, please contact your local law enforcement agency for guidance.
Respira Therapeutics, Inc.
生物技术研究
Palo Alto，California 1,575 位关注者
Improving patient outcomes through enhanced drug targeting to the lung
关于我们
Respira Therapeutics is developing inhaled therapeutics for cardiopulmonary diseases that improve patient outcomes through enhanced drug targeting to the small airways of the lung. Respira combines proprietary dry-powder inhaler device technologies and advanced particle engineering-based inhaled drug formulation approaches to develop novel therapeutics that deliver the drug where it needs to be —in the lung and lung periphery, instead of in the oropharyngeal cavity. Respira’s lead product candidate, RT234-PAH, has received FDA Orphan Drug Designation for Pulmonary Arterial Hypertension and is in Phase 2 clinical trials as a first-in-class inhaled therapeutic for as-needed use to provide acute relief for the most commonly reported symptoms in PAH patients.
- 网站
-
https://www.respiratherapeutics.com
Respira Therapeutics, Inc.的外部链接
- 所属行业
- 生物技术研究
- 规模
- 2-10 人
- 总部
- Palo Alto，California
- 类型
- 私人持股
- 创立
- 2010
地点
-
主要
获取路线
Middlefield Rd
US，California，Palo Alto